Dietary intake of antioxidants and risk of Alzheimer disease
- PMID: 12076218
- DOI: 10.1001/jama.287.24.3223
Dietary intake of antioxidants and risk of Alzheimer disease
Abstract
Context: Laboratory findings have suggested that oxidative stress may contribute to the pathogenesis of Alzheimer disease. Therefore, the risk of Alzheimer disease might be reduced by intake of antioxidants that counteract the detrimental effects of oxidative stress.
Objective: To determine whether dietary intake of antioxidants is related to risk of Alzheimer disease.
Design and setting: The Rotterdam Study, a population-based, prospective cohort study conducted in the Netherlands.
Participants: A total of 5395 participants who, at baseline (1990-1993), were aged at least 55 years, free of dementia, and noninstitutionalized and had reliable dietary assessment. Participants were reexamined in 1993-1994 and 1997-1999 and were continuously monitored for incident dementia.
Main outcome measures: Incidence of Alzheimer disease, based on Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) criteria and National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) criteria, associated with dietary intake of beta carotene, flavonoids, vitamin C, and vitamin E.
Results: After a mean follow-up of 6 years, 197 participants developed dementia, of whom 146 had Alzheimer disease. When adjustments were made for age, sex, baseline Mini-Mental State Examination score, alcohol intake, education, smoking habits, pack-years of smoking, body mass index, total energy intake, presence of carotid plaques, and use of antioxidative supplements, high intake of vitamin C and vitamin E was associated with lower risk of Alzheimer disease (rate ratios [RRs] per 1-SD increase in intake were 0.82 [95% confidence interval [CI], 0.68-0.99] and 0.82 [95% CI, 0.66-1.00], respectively). Among current smokers, this relationship was most pronounced (RRs, 0.65 [95% CI, 0.37-1.14] and 0.58 [95% CI, 0.30-1.12], respectively) and also was present for intake of beta carotene (RR, 0.49 [95% CI, 0.27-0.92]) and flavonoids (RR, 0.54 [95% CI, 0.31-0.96]). The associations did not vary by education or apolipoprotein E genotype.
Conclusion: High dietary intake of vitamin C and vitamin E may lower the risk of Alzheimer disease.
Comment in
-
Dietary intake of antioxidants and risk of Alzheimer disease: food for thought.JAMA. 2002 Jun 26;287(24):3261-3. doi: 10.1001/jama.287.24.3261. JAMA. 2002. PMID: 12076225 No abstract available.
-
Antioxidants and risk of Alzheimer disease.JAMA. 2002 Nov 13;288(18):2265; author reply 2265-6. JAMA. 2002. PMID: 12425701 No abstract available.
-
Antioxidants and risk of Alzheimer disease.JAMA. 2002 Nov 13;288(18):2265; author reply 2265-6. JAMA. 2002. PMID: 12425702 No abstract available.
Similar articles
-
Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.JAMA. 2002 Jun 26;287(24):3230-7. doi: 10.1001/jama.287.24.3230. JAMA. 2002. PMID: 12076219
-
Dietary antioxidants and long-term risk of dementia.Arch Neurol. 2010 Jul;67(7):819-25. doi: 10.1001/archneurol.2010.144. Arch Neurol. 2010. PMID: 20625087 Free PMC article.
-
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.J Natl Cancer Inst. 2006 Feb 15;98(4):245-54. doi: 10.1093/jnci/djj050. J Natl Cancer Inst. 2006. PMID: 16478743
-
[Could intake of vitamins C and E inhibit development of Alzheimer dementia?].Tidsskr Nor Laegeforen. 2006 Jan 12;126(2):159-61. Tidsskr Nor Laegeforen. 2006. PMID: 16415937 Review. Norwegian.
-
Association of antioxidants intake in diet and supplements with risk of Alzheimer's disease: a systematic review and dose-response meta-analysis of prospective cohort studies.Aging Clin Exp Res. 2025 May 26;37(1):166. doi: 10.1007/s40520-024-02893-6. Aging Clin Exp Res. 2025. PMID: 40415164 Free PMC article.
Cited by
-
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research.Br J Clin Pharmacol. 2013 Mar;75(3):738-55. doi: 10.1111/bcp.12058. Br J Clin Pharmacol. 2013. PMID: 23384081 Free PMC article. Review.
-
Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach.Ann N Y Acad Sci. 2016 Mar;1367(1):50-6. doi: 10.1111/nyas.13070. Ann N Y Acad Sci. 2016. PMID: 27116241 Free PMC article. Review.
-
Integrated treatment approach improves cognitive function in demented and clinically depressed patients.Am J Alzheimers Dis Other Demen. 2005 Jan-Feb;20(1):21-6. doi: 10.1177/153331750502000103. Am J Alzheimers Dis Other Demen. 2005. PMID: 15751450 Free PMC article.
-
Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway.Neuropsychiatr Dis Treat. 2022 Mar 4;18:513-524. doi: 10.2147/NDT.S346238. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 35280979 Free PMC article.
-
The role of nutrition in Alzheimer's disease: epidemiological evidence.Eur J Neurol. 2009 Sep;16 Suppl 1(Suppl 1):1-7. doi: 10.1111/j.1468-1331.2009.02735.x. Eur J Neurol. 2009. PMID: 19703213 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical